Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agenus Inc | Garo H. Armen | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 2,400,000 | 2,400,000 | - | - | Stock Option | |
| U.S. Energy Corp | Duane H. King | Director | Other type of transaction at price $ 0.00 per share. | 05 Jan 2023 | 2,027,399 | 2,027,399 (144%) | 144% | 0 | Common Stock | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 2,019,206 | 7,213,236 (10%) | 2% | 0 | Common Stock | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 2,019,206 | 0 (0%) | 2% | 0 | Common Stock | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 2,019,206 | 992,381 (1%) | 2% | 0 | Common Stock | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 2,019,206 | 2,019,206 (2%) | 2% | 0 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 2,019,026 | 7,213,236 (10%) | 2% | 0 | Common Stock | |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 1,330,260 | 3,223,083 (0%) | 0% | 0 | Class C Capital Stock | |
| Ardelyx Inc | Michael G. Raab | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 1,124,000 | 1,124,000 | - | - | Stock Option (Right to Buy) | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 992,381 | 0 (0%) | 1% | 0 | Common Stock | |
| Celsius Holdings Inc | William H. Milmoe | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 870,000 | 5,194,030 (7%) | 1% | 0 | Common Stock | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 870,000 | 5,194,030 (7%) | 1% | 0 | Common Stock | |
| Celsius Holdings Inc | Carl Desantis | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 870,000 | 0 (0%) | 1% | 0 | Common Stock | |
| Alphabet (Class A) | Sundar Pichai | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.71 per share. | 05 Jan 2023 | 657,904 | 2,565,179 (0%) | 0% | 88.7 | 58,362,664 | Class C Capital Stock |
| XWELL Inc | Bruce T. Bernstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 600,000 | 600,000 | - | - | Stock Option (right to buy) | |
| V2X Inc | John Boyington | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 517,918 | 517,918 (4%) | 4% | 0 | V2X, Inc. Common Stock | |
| V2X Inc | John Boyington | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 517,918 | 0 | - | - | Restricted Stock Units | |
| WM Tech Inc (Class A) | Douglas Francis | Director, Executive Chair, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 05 Jan 2023 | 481,927 | 4,792,347 | - | 0 | Class A Common Stock | |
| PDS biotech Corp | Frank Bedu-Addo | Director, President/CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 385,300 | 385,300 | - | - | Employee Stock Option (Right to Buy) | |
| Urban One Inc (Class A) | C. Liggins Alfred | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 383,781 | 12,902,406 (33%) | 0% | 0 | Class D Common Stock | |
| Ardelyx Inc | Justin A. Renz | Chief Financial Officer | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | David P. Rosenbaum | Chief Development Officer | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Elizabeth Grammer | See Remarks | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Robert Blanks | See Remarks | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | ||
| Ardelyx Inc | Laura Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 351,000 | 351,000 | - | - | Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Keith C. Valentine | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 338,264 | 338,264 | - | - | Employee Stock Option (Right to Buy) | |
| XWELL Inc | Robert Weinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| XWELL Inc | Donald Stout | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| XWELL Inc | Michael Lebowitz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 300,000 | 300,000 | - | - | Stock Option (right to buy) | |
| Urban One Inc (Class A) | C. Liggins Alfred | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 261,076 | 2,635,261 | - | - | Stock Option (Class D) | |
| Energy Focus Inc | Mei Yun Gina Huang | Director, Ten Percent Owner | 05 Jan 2023 | 257,798 | 639,630 (4%) | 1% | 0.4 | 100,000 | Common Stock | |
| Ardelyx Inc | Michael G. Raab | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 250,000 | 909,461 (1%) | 0% | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 250,000 | 475,554 | - | 0 | Ordinary Shares | |
| Agenus Inc | Garo H. Armen | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 2.45 per share. | 05 Jan 2023 | 241,383 | 1,249,167 (0%) | 0% | 2.4 | 591,388 | Common Stock |
| Celsius Holdings Inc | Damon DeSantis | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 232,994 | 239,049 (0%) | 0% | - | Common Stock | |
| Urban One Inc (Class A) | L. Hughes Catherine | Director, Chairperson & Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 230,269 | 4,872,349 (12%) | 0% | 0 | Class D Common Stock | |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| V2X Inc | John Boyington | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.64 per share. | 05 Jan 2023 | 200,394 | 317,524 (2%) | 1% | 41.6 | 8,344,406 | V2X, Inc. Common Stock |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 200,000 | 200,000 | - | - | Stock Option | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 05 Jan 2023 | 187,500 | 13,583 (0%) | 0% | 108 | 20,250,000 | Ordinary Shares |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 187,500 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 05 Jan 2023 | 187,500 | 201,083 (0%) | 0% | 7.2 | 1,340,625 | Ordinary Shares |
| Knowles Corp | Jeffrey S. Niew | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.29 per share. | 05 Jan 2023 | 185,542 | 604,247 (0%) | 0% | 17.3 | 3,208,021 | Common Stock |
| Aemetis Inc | Eric A. McAfee | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 180,000 | 3,017,136 (14%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 179,410 | 600,560 | - | 0 | Class A Common Stock | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 179,410 | 2,152,960 | - | - | Restricted Stock Unit (RSU) | |
| US Foods Holding Corp | David E. Flitman | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 168,162 | 168,162 | - | - | Restricted Stock Units | |
| U.S. Energy Corp | Ryan L. Smith | Director, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 163,043 | 659,343 (47%) | 11% | 0 | Common Stock | |
| Agenus Inc | Christine M. Klaskin | PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 162,916 | 162,916 | - | - | Stock Option | |
| Dropbox Inc (Class A) | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | 05 Jan 2023 | 162,500 | 162,500 (0%) | 0% | 0 | Class A Common Stock | ||
| Dropbox Inc (Class A) | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 22.14 per share. | 05 Jan 2023 | 162,500 | 0 (0%) | 0% | 22.1 | 3,597,441 | Class A Common Stock |
| Dropbox Inc (Class A) | Andrew W. Houston | Director, Chief Executive Officer, Ten Percent Owner | 05 Jan 2023 | 162,500 | 72,425,573 | - | - | Class B Common Stock | ||
| Urban One Inc (Class A) | Hughes Catherine L. | Director, Chairperson & Secretary, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 156,645 | 1,521,956 | - | - | Stock Option (Class D) | |
| Xos Inc | Dakota Semler | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.94 per share. | 05 Jan 2023 | 155,189 | 3,453,229 | - | 0.9 | 145,878 | Common Stock |
| XWELL Inc | Scott R Milford | Director, Pres & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 150,000 | 150,000 | - | - | Employee stock option (right to buy) | |
| Zymeworks BC Inc | Kenneth Galbraith | Director, Chair & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 143,000 | 143,000 | - | - | Restricted Stock Unit | |
| Orthofix Medical Inc | Keith C. Valentine | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 140,515 | 399,855 (2%) | 0% | 0 | Common Stock | |
| Aemetis Inc | Andrew B. Foster | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 137,500 | 137,500 | - | - | Option (right to buy) | |
| Aemetis Inc | Sanjeev Gupta | Executive Vice President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 137,500 | 137,500 | - | - | Option (right to buy) | |
| Aemetis Inc | Todd A. Waltz | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 137,500 | 137,500 | - | - | Option (right to buy) | |
| PDS biotech Corp | Gregory L. Conn | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 137,200 | 137,200 | - | - | Employee Stock Option (Right to Buy) | |
| Great Elm Grp Inc | Jason W. Reese | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 135,747 | 730,061 (2%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 132,500 | 132,500 | - | - | Stock Option (Right to Buy) | |
| Urban One Inc (Class A) | Peter D. Thompson | CFO/EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 131,402 | 585,471 (1%) | 0% | 0 | Class D Common Stock | |
| ALT5 Sigma Corp | Antonios Isaac | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 125,787 | 217,787 (11%) | 6% | 0 | Common Stock | |
| NeuroPace Inc | Uri Geiger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 120,521 | 120,521 | - | - | Stock Option (Right to Buy) | |
| Ardelyx Inc | Robert Felsch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| BridgeBio Pharma Inc | Neil Kumar | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 7.67 per share. | 05 Jan 2023 | 120,000 | 1,492,722 (1%) | 0% | 7.7 | 920,856 | Common Stock |
| Ardelyx Inc | David P. Rosenbaum | Chief Development Officer | 05 Jan 2023 | 116,250 | 116,250 | - | - | Stock Option (Right to Buy) | ||
| Urban One Inc (Class A) | David Kantor M. | CEO, Radio Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 114,198 | 387,725 (1%) | 0% | 0 | Class D Common Stock | |
| Urban One Inc (Class A) | Alfred Liggins C. | Director, CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Jan 2023 | 112,203 | 12,790,203 (33%) | 0% | 3.7 | 416,273 | Class D Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.07 per share. | 05 Jan 2023 | 110,962 | 712,440 (0%) | 0% | 12.1 | 1,339,311 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 110,962 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Ironwood Pharma Inc (Class A) | Thomas A. McCourt | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.65 per share. | 05 Jan 2023 | 110,962 | 823,402 (0%) | 0% | 11.6 | 1,292,707 | Class A Common Stock |
| PDS biotech Corp | Lauren Wood | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 110,800 | 110,800 | - | - | Employee Stock Option (Right to Buy) | |
| Agenus Inc | Steven J. O'Day | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 2.45 per share. | 05 Jan 2023 | 109,381 | 272,384 (0%) | 0% | 2.4 | 267,983 | Common Stock |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 103,705 | 14,233,908 | - | - | Class C Common Stock | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2023 | 103,705 | 421,150 | - | 0 | Class A Common Stock | |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 102,540 | 102,540 | - | - | Stock Option (right to buy) | |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 100,000 | 685,252 | - | 0 | Ordinary Shares | |
| XWELL Inc | Ezra Ernst | CEO XprsTst, Exc VP XWELL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | |
| XWELL Inc | Omar A. Haynes | Interim CFO | 05 Jan 2023 | 100,000 | 100,000 | - | - | Employee stock option (right to buy) | ||
| Exelixis Inc | Dana T. Aftab | CSO/EVP Disc & Trans Research | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 100,000 | 353,001 (0%) | 0% | 0 | Common Stock | |
| U.S. Energy Corp | Donald Aloysius Kessel | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 100,000 | 237,274 (16%) | 7% | 0 | Common Stock | |
| U.S. Energy Corp | John A. Weinzierl | Director, Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 97,826 | 297,826 (21%) | 6% | 0 | Common Stock | |
| Great Elm Grp Inc | Matthew A. Drapkin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 97,285 | 403,408 (1%) | 0% | 0 | Common Stock | |
| Tejon Ranch Co. | Gregory S. Bielli | Director, President/ CEO | Grant, award, or other acquisition of securities at price $ 18.84 per share. | 05 Jan 2023 | 93,162 | 465,488 (1%) | 0% | 18.8 | 1,755,172 | Tejon Ranch Co. Common Stock |
| Urban One Inc (Class A) | Thompson D. Peter | CFO/EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 89,389 | 598,075 | - | - | Stock Option (Class D) | |
| Kopin Corp | Boryeu Tsaur | Executive Vice President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2023 | 88,300 | 106,411 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Neil Klompas | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 87,500 | 87,500 | - | - | Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Patrick L. Keran | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 84,566 | 84,566 | - | - | Employee Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Kimberley A. Elting | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 84,566 | 84,566 | - | - | Employee Stock Option (Right to Buy) | |
| Orthofix Medical Inc | John J. Bostjancic | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 84,566 | 84,566 | - | - | Employee Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 81,967 | 358,110 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 81,967 | 358,110 (1%) | 0% | 0 | Common Stock | |
| Xos Inc | Dakota Semler | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 05 Jan 2023 | 80,000 | 3,298,040 | - | 0.8 | 64,800 | Common Stock |
| ALT5 Sigma Corp | Virland A. Johnson | Chief Financial Officer | 05 Jan 2023 | 78,617 | 78,617 (4%) | 4% | 0 | Common Stock | ||
| Urban One Inc (Class A) | Hughes Catherine L. | Director, Chairperson & Secretary, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Jan 2023 | 78,100 | 4,794,249 (12%) | 0% | 3.7 | 289,751 | Class D Common Stock |
| Ardelyx Inc | Justin A. Renz | Chief Financial Officer | 05 Jan 2023 | 78,000 | 340,045 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | David P. Rosenbaum | Chief Development Officer | 05 Jan 2023 | 78,000 | 378,994 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | Elizabeth Grammer | See Remarks | 05 Jan 2023 | 78,000 | 332,868 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | Susan Rodriguez | Chief Commercial Officer | 05 Jan 2023 | 78,000 | 360,717 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | Robert Blanks | See Remarks | 05 Jan 2023 | 78,000 | 272,363 (0%) | 0% | 0 | Common Stock | ||
| Ardelyx Inc | Laura Williams | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 78,000 | 322,200 (0%) | 0% | 0 | Common Stock | |
| Urban One Inc (Class A) | Kantor M. David | CEO, Radio Division | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 77,686 | 272,498 | - | - | Stock Option (Class D) | |
| Zymeworks BC Inc | Paul Andrew Moore | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 77,500 | 77,500 | - | - | Stock Option (Right to Buy) | |
| Tejon Ranch Co. | Gregory S. Bielli | Director, President/ CEO | Grant, award, or other acquisition of securities at price $ 18.66 per share. | 05 Jan 2023 | 76,787 | 414,060 (1%) | 0% | 18.7 | 1,432,845 | Tejon Ranch Co. Common Stock |
| Charter (Class A) | Michael A. Newhouse | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Jan 2023 | 76,308 | 18,099,912 | - | - | Class B Common Units of Charter Communications Holdings, LLC | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 05 Jan 2023 | 75,705 | 524,855 | - | 2.4 | 180,935 | Class A Common Stock |
| Compass Inc (Class A) | Gregory M. Hart | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 68,466 | 521,080 | - | 0 | Class A Common Stock | |
| PTC Therapeutics Inc | Matthew B. Klein | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | |
| Urban One Inc (Class A) | Peter D. Thompson | CFO/EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Jan 2023 | 64,829 | 520,642 (1%) | 0% | 3.7 | 240,516 | Class D Common Stock |
| BridgeBio Pharma Inc | Brian C. Stephenson | Secretary, Treasurer & CFO | 05 Jan 2023 | 61,040 | 280,224 (0%) | 0% | 7.7 | 468,470 | Common Stock | |
| Zymeworks BC Inc | Neil Klompas | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 58,500 | 58,500 | - | - | Restricted Stock Unit | |
| Thryv Holdings Inc | Joseph A. Walsh | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 54,460 | 420,812 | - | 0 | Common Shares | |
| FTC Solar Inc | Sean Hunkler | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 05 Jan 2023 | 53,300 | 604,138 | - | 2.6 | 136,981 | Common Stock |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 53,000 | 173,485 (0%) | 0% | 0 | Common Stock | |
| Zymeworks BC Inc | Paul Andrew Moore | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 51,500 | 51,500 | - | - | Restricted Stock Unit | |
| Werner Enterprises Inc | J. Leathers Derek | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 51,303 | 444,433 (0%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Gregory M. Hart | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 51,176 | 51,176 | - | - | Restricted Stock Unit (RSU) | |
| Tejon Ranch Co. | Gregory S. Bielli | Director, President/ CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.84 per share. | 05 Jan 2023 | 51,138 | 414,350 (1%) | 0% | 18.8 | 963,440 | Tejon Ranch Co. Common Stock |
| ENvue Medical Inc | Thomas R. Mika | Director | 05 Jan 2023 | 50,000 | 50,000 (1%) | 1% | 0.3 | 12,500 | Common Stock | |
| U.S. Energy Corp | James W. Denny | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 48,913 | 103,913 (7%) | 3% | 0 | Common Stock | |
| U.S. Energy Corp | D. Stephen Slack | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 48,913 | 108,913 (7%) | 3% | 0 | Common Stock | |
| U.S. Energy Corp | Randall D. Keys | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 48,913 | 128,913 (9%) | 3% | 0 | Common Stock | |
| U.S. Energy Corp | Duane H. King | Director | Other type of transaction at price $ 0.00 per share. | 05 Jan 2023 | 48,913 | 88,913 (6%) | 3% | 0 | Common Stock | |
| U.S. Energy Corp | Joshua L. Batchelor | Director, Ten Percent Owner, Member of 10% owner group | 05 Jan 2023 | 48,913 | 48,913 (3%) | 3% | 0 | Common Stock | ||
| Zymeworks BC Inc | Christopher Astle | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 47,000 | 47,000 | - | - | Stock Option (Right to Buy) | |
| APA | John J. Christmann | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 45,958 | 299,109 | - | - | Restricted Stock / Units | |
| APA | John J. Christmann | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 45,958 | 530,077 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,872 | 235,379 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,872 | 235,379 (1%) | 0% | 0 | Common Stock | |
| Thryv Holdings Inc | Paul D. Rouse | CFO, Executive VP & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,383 | 107,873 | - | 0 | Common Shares | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| Urban One Inc (Class A) | Wishart Karen | CAO/EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 44,474 | 108,354 (0%) | 0% | 0 | Class D Common Stock | |
| Great Elm Grp Inc | James H. Hugar | Director | 05 Jan 2023 | 42,986 | 238,939 (0%) | 0% | 0 | Common Stock | ||
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 42,500 | 42,500 | - | - | Stock Option (Right to Buy) | |
| Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 42,481 | 67,310 (0%) | 0% | 0 | Common Stock | |
| Tejon Ranch Co. | Gregory S. Bielli | Director, President/ CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.66 per share. | 05 Jan 2023 | 41,734 | 372,326 (1%) | 0% | 18.7 | 778,756 | Tejon Ranch Co. Common Stock |
| Vroom Inc | Thomas H. Shortt | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 05 Jan 2023 | 41,592 | 1,419,869 | - | 1.0 | 42,998 | Common Stock |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 40,764 | 276,143 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jon Carl Serbousek | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 40,764 | 276,143 (1%) | 0% | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 05 Jan 2023 | 40,000 | 800,000 | - | 12.3 | 492,220 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | Chi Fung Cheng | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.31 per share. | 05 Jan 2023 | 40,000 | 11,383,602 | - | 12.3 | 492,280 | Ordinary Shares |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 39,740 | 317,921 | - | - | Stock Option (Right to Buy) | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.84 per share. | 05 Jan 2023 | 39,740 | 387,236 (0%) | 0% | 1.8 | 73,122 | Common Stock, $0.01 par value |
| GlycoMimetics Inc | Sandell D Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.76 per share. | 05 Jan 2023 | 39,223 | 4,737,613 (10%) | 0% | 2.8 | 108,201 | Common Stock |
| AlTi Global Inc (Class A) | Peter M. Yu | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.38 per share. | 05 Jan 2023 | 39,056 | 148,996 | - | 8.4 | 327,289 | Class A Common Stock |
| Great Elm Grp Inc | Eric J. Scheyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 38,462 | 259,087 (1%) | 0% | 0 | Common Stock | |
| Great Elm Grp Inc | Jim Parmelee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 38,462 | 275,299 (1%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Scott Wahlers | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 37,793 | 160,937 | - | 0 | Class A Common Stock | |
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 37,760 | 37,760 | - | - | Stock Option (right to buy) | |
| Teradata Corp | Todd Cione | Chief Revenue Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.81 per share. | 05 Jan 2023 | 36,420 | 162,766 (0%) | 0% | 33.8 | 1,231,360 | Common Stock |
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 36,250 | 36,250 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 36,250 | 36,250 | - | - | Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Kimberley A. Elting | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 35,129 | 140,924 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Patrick L. Keran | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 35,128 | 89,198 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | John J. Bostjancic | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 35,128 | 105,147 (0%) | 0% | 0 | Common Stock | |
| Insmed Inc | Drayton Wise | Chief Commercial Officer | 05 Jan 2023 | 34,860 | 34,860 | - | - | Stock Option (right to buy) | ||
| Insmed Inc | Roger Adsett | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 34,860 | 34,860 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 34,860 | 34,860 | - | - | Stock Option (right to buy) | |
| Compass Inc (Class A) | Scott Wahlers | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 34,413 | 0 | - | - | Restricted Stock Unit (RSU) | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.46 per share. | 05 Jan 2023 | 34,129 | 353,107 (0%) | 0% | 55.5 | 1,892,654 | Common Stock, $0.01 par value |
| Great Elm Grp Inc | David Matter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 33,937 | 330,445 (1%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| GlycoMimetics Inc | Sandell D Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.76 per share. | 05 Jan 2023 | 32,139 | 3,881,933 (8%) | 0% | 2.8 | 88,659 | Common Stock |
| Thryv Holdings Inc | Gordon Henry | Chief Strategy Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 31,768 | 60,867 | - | 0 | Common Shares | |
| Thryv Holdings Inc | John F. Wholey | Executive VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 31,768 | 155,381 | - | 0 | Common Stock | |
| Thryv Holdings Inc | James McCusker | Chief Revenue Officer and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 31,768 | 67,136 | - | 0 | Common Shares | |
| Thryv Holdings Inc | Lesley Bolger | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 31,768 | 54,768 | - | 0 | Common Stock | |
| Zymeworks BC Inc | Christopher Astle | SVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 31,500 | 31,500 | - | - | Restricted Stock Unit | |
| Agenus Inc | Christine M. Klaskin | PFO & PAO | Grant, award, or other acquisition of securities at price $ 2.45 per share. | 05 Jan 2023 | 31,294 | 153,937 (0%) | 0% | 2.4 | 76,670 | Common Stock |
| APA | John J. Christmann | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 30,638 | 542,630 (0%) | 0% | - | Common Stock | |
| APA | John J. Christmann | Director, CEO and President | Sale or transfer of securities back to the company at price $ 41.76 per share. | 05 Jan 2023 | 30,638 | 511,992 (0%) | 0% | 41.8 | 1,279,443 | Common Stock |
| APA | John J. Christmann | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 30,638 | 268,471 | - | - | Restricted Stock / Units | |
| Urban One Inc (Class A) | Karen Wishart | CAO/EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 30,350 | 82,233 | - | - | Stock Option (Class D) | |
| Unity Software Inc | Clive Downie | SVP & GM, Consumer | Other type of transaction at price $ 0.00 per share. | 05 Jan 2023 | 30,000 | 236,821 | - | 0 | Common Stock | |
| Urban One Inc (Class A) | David M. Kantor | CEO, Radio Division | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Jan 2023 | 29,664 | 358,061 (0%) | 0% | 3.7 | 110,053 | Class D Common Stock |
| Great Elm Grp Inc | Matthew A. Drapkin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,412 | 306,123 (1%) | 0% | 0 | Common Stock | |
| Great Elm Grp Inc | James H. Hugar | Director | 05 Jan 2023 | 29,412 | 195,953 (0%) | 0% | 0 | Common Stock | ||
| Great Elm Grp Inc | Eric J. Scheyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,412 | 220,625 (0%) | 0% | 0 | Common Stock | |
| Great Elm Grp Inc | Jim Parmelee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,412 | 236,837 (0%) | 0% | 0 | Common Stock | |
| Great Elm Grp Inc | Jason W. Reese | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,412 | 594,314 (2%) | 0% | 0 | Common Stock | |
| Great Elm Grp Inc | David Matter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,412 | 296,508 (1%) | 0% | 0 | Common Stock | |
| V2X Inc | William Wayne Beard | SVP, Aerospace Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 29,315 | 87,943 | - | - | Restricted Stock Units | |
| V2X Inc | William Wayne Beard | SVP, Aerospace Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 29,315 | 29,315 (0%) | 0% | 0 | V2X, Inc. Common Stock | |
| Insmed Inc | S. Nicole Schaeffer | Chief People Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,050 | 29,050 | - | - | Stock Option (right to buy) | |
| Insmed Inc | Michael Smith | General Counsel, Senior VP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 29,050 | 29,050 | - | - | Stock Option (right to buy) | |
| Heico Corp (Class A) | Alan Schriesheim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 28,156 | 164,893 | - | - | Option (Right to purchase Common Stock) | |
| Heico Corp (Class A) | Alan Schriesheim | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.57 per share. | 05 Jan 2023 | 28,156 | 123,608 (0%) | 0% | 0.6 | 16,086 | Common Stock |
| Nephros Inc | Arthur H. Amron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 27,613 | 27,613 (0%) | 0% | 0 | Common Stock | |
| Nephros Inc | Alisa Lask | Director | 05 Jan 2023 | 27,613 | 39,338 (0%) | 0% | 0 | Common Stock | ||
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 27,613 | 43,226 (0%) | 0% | 0 | Common Stock | |
| Urban One Inc (Class A) | Simpson Kristopher | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 27,291 | 36,501 (0%) | 0% | 0 | Class D Common Stock | |
| Rafael Holdings Inc (Class B) | Mark A. Mccamish | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 32,586 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc (Class B) | Stephen Greenberg | Director | 05 Jan 2023 | 27,174 | 47,295 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share | |
| Rafael Holdings Inc (Class B) | Boris C. Pasche | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 47,295 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Rafael Holdings Inc (Class B) | Michael J. Weiss | Director | Grant, award, or other acquisition of securities at price $ 1.84 per share. | 05 Jan 2023 | 27,174 | 47,295 (0%) | 0% | 1.8 | 50,000 | Class B Common Stock, par value $.01 per share |
| Tradeweb Markets Inc - Ordinary Shares Cls A | William Hult | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.82 per share. | 05 Jan 2023 | 26,247 | 125,672 (0%) | 0% | 63.8 | 1,675,128 | Class A common stock |
| Ardelyx Inc | Robert Felsch | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 26,000 | 117,418 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Matthew B. Klein | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 26,000 | 83,104 (0%) | 0% | 0 | Common Stock | |
| Ardelyx Inc | David P. Rosenbaum | Chief Development Officer | 05 Jan 2023 | 25,325 | 114,210 (0%) | 0% | 0 | Common Stock | ||
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 25,000 | 0 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 05 Jan 2023 | 25,000 | 38,583 (0%) | 0% | 11.5 | 286,500 | Ordinary Shares |
| Roivant Sciences Ltd | Eric Venker | President & COO | Sale of securities on an exchange or to another person at price $ 8.02 per share. | 05 Jan 2023 | 24,037 | 729,429 | - | 8.0 | 192,777 | Common Shares |
| Iridium Comm Inc | Matthew J. Desch | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.30 per share. | 05 Jan 2023 | 22,433 | 604,299 (0%) | 0% | 54.3 | 1,218,112 | Common Stock |
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 22,353 | 272,061 (0%) | 0% | - | Common Stock | |
| AlTi Global Inc (Class A) | Peter M. Yu | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.98 per share. | 05 Jan 2023 | 22,231 | 171,227 | - | 9.0 | 199,634 | Class A Common Stock |
| Avnet Inc | Philip R. Gallagher | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.53 per share. | 05 Jan 2023 | 22,105 | 176,334 (0%) | 0% | 41.5 | 918,021 | Common Stock |
| One Liberty Properties Inc | Patrick Callan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 21,750 | 342,193 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Kimberley A. Elting | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 20,492 | 185,179 (0%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Gregory M. Hart | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 05 Jan 2023 | 20,482 | 500,598 | - | 2.4 | 48,952 | Class A Common Stock |
| PDS biotech Corp | Spencer D. Brown | Senior VP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 20,400 | 20,400 | - | - | Employee Stock Option (Right to Buy) | |
| Crowdstrike (Class A) | Roxanne S. Austin | Director | Purchase of securities on an exchange or from another person at price $ 95.14 per share. | 05 Jan 2023 | 20,000 | 85,419 (0%) | 0% | 95.1 | 1,902,800 | Class A common stock |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 19,654 | 42,966 (0%) | 0% | 0 | Common Stock | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 19,654 | 136,588 | - | - | Restricted Stock / Units | |
| PTC Therapeutics Inc | Emily Hill | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 19,500 | 48,759 (0%) | 0% | 0 | Common Stock | |
| United Community Banks Inc | H. Lynn Harton | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,879 | 149,981 (0%) | 0% | 0 | Common Stock | |
| Urban One Inc (Class A) | Simpson Kristopher | SVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,565 | 42,622 | - | - | Stock Option (Class D) | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 18,500 | 601,305 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.39 per share. | 05 Jan 2023 | 18,500 | 582,805 | - | 7.4 | 136,669 | Class A Common Stock |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 18,500 | 6,601,834 | - | - | Class B Common Stock | ||
| V2X Inc | Richard Mendoza | SVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 18,207 | 54,620 | - | - | Restricted Stock Units | |
| V2X Inc | Richard Mendoza | SVP, Chief People Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 18,207 | 18,207 (0%) | 0% | 0 | V2X, Inc. Common Stock | |
| APA | John J. Christmann | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.76 per share. | 05 Jan 2023 | 18,085 | 511,992 (0%) | 0% | 41.8 | 755,230 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,000 | 68,363 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Stuart W. Peltz | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,000 | 56,830 (0%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Gregory M. Hart | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 17,290 | 484,000 | - | - | Restricted Stock Unit (RSU) | |
| One Liberty Properties Inc | Lawrence G. Ricketts | Exec.Vice President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 17,100 | 189,164 (0%) | 0% | 0 | Common Stock | |
| Ouster Inc (Class A) | Susan Heystee | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 05 Jan 2023 | 17,089 | 564,847 | - | 1.1 | 19,061 | Common Stock |
| Urban One Inc (Class A) | Wishart Karen | CAO/EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Jan 2023 | 17,076 | 91,278 (0%) | 0% | 3.7 | 63,352 | Class D Common Stock |
| Aemetis Inc | Francis P. Barton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 17,070 | 163,522 (0%) | 0% | 0 | Common Stock | |
| Compass Inc (Class A) | Bradley K. Serwin | General Counsel and Secretary | 05 Jan 2023 | 17,059 | 17,059 | - | - | Restricted Stock Unit (RSU) | ||
| Compass Inc (Class A) | Bradley K. Serwin | General Counsel and Secretary | 05 Jan 2023 | 17,059 | 136,311 | - | 0 | Class A Common Stock | ||
| PTC Therapeutics Inc | Mark E. Boulding | EXEC. VP AND CLO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 17,000 | 78,110 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Neil Almstead | CHIEF TECHNICAL OPS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 17,000 | 66,151 (0%) | 0% | 0 | Common Stock | |
| Teradata Corp | Todd Cione | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 33.56 per share. | 05 Jan 2023 | 16,840 | 145,926 (0%) | 0% | 33.6 | 565,150 | Common Stock |
| FTC Solar Inc | Robert Phelps Morris | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 05 Jan 2023 | 16,839 | 204,740 | - | 2.6 | 43,276 | Common Stock |
| Compass Inc (Class A) | Scott Wahlers | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.39 per share. | 05 Jan 2023 | 15,806 | 145,131 | - | 2.4 | 37,776 | Class A Common Stock |
| Crowdstrike (Class A) | Roxanne S. Austin | Director | Purchase of securities on an exchange or from another person at price $ 99.00 per share. | 05 Jan 2023 | 15,500 | 115,919 (0%) | 0% | 99 | 1,534,500 | Class A common stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | William Hult | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 63.18 per share. | 05 Jan 2023 | 15,013 | 151,919 (0%) | 0% | 63.2 | 948,583 | Class A common stock |
| Crowdstrike (Class A) | Roxanne S. Austin | Director | Purchase of securities on an exchange or from another person at price $ 97.59 per share. | 05 Jan 2023 | 15,000 | 100,419 (0%) | 0% | 97.6 | 1,463,900 | Class A common stock |
| Xos Inc | Dakota Semler | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 05 Jan 2023 | 15,000 | 3,218,040 | - | 0.6 | 9,600 | Common Stock |
| Ouster Inc (Class A) | Emmanuel T. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 05 Jan 2023 | 14,792 | 153,546 | - | 1.1 | 16,499 | Common Stock |
| Urban One Inc (Class A) | Kristopher Simpson | SVP & General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.71 per share. | 05 Jan 2023 | 14,506 | 21,995 (0%) | 0% | 3.7 | 53,817 | Class D Common Stock |
| Orthofix Medical Inc | Catherine M. Burzik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 33,056 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Jason M. Hannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 31,587 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 48,762 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Stuart M. Essig | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 205,966 (1%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | James Hinrichs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 77,859 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | Michael E. Paolucci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 48,989 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Christine Utter | SVP, FINANCE & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,000 | 39,996 (0%) | 0% | 0 | Common Stock | |
| Huron Consulting Grp Inc | James H. Roth | Director | Sale of securities on an exchange or to another person at price $ 68.23 per share. | 05 Jan 2023 | 13,841 | 89,785 (0%) | 0% | 68.2 | 944,371 | Common Stock |
| Aemetis Inc | Lydia I. Beebe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 13,570 | 152,441 (0%) | 0% | 0 | Common Stock | |
| Ecovyst Inc | Kurt J. Bitting | Director, See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.04 per share. | 05 Jan 2023 | 13,362 | 358,709 (0%) | 0% | 9.0 | 120,726 | Common Stock |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 13,350 | 75,887 (0%) | 0% | 0 | Common Stock | |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 13,350 | 93,430 | - | - | Restricted Stock / Units | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 13,102 | 123,486 | - | - | Restricted Stock / Units | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 13,102 | 48,334 (0%) | 0% | - | Common Stock | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Sale or transfer of securities back to the company at price $ 41.76 per share. | 05 Jan 2023 | 13,102 | 35,232 (0%) | 0% | 41.8 | 547,140 | Common Stock |
| Urban One Inc (Class A) | Kristopher Simpson | SVP & General Counsel | Sale or transfer of securities back to the company at price $ 3.71 per share. | 05 Jan 2023 | 12,785 | 9,210 (0%) | 0% | 3.7 | 47,432 | Class D Common Stock |
| BRT Apartments Corp | Mark H. Lundy | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 12,640 | 247,122 (1%) | 0% | 0 | Common Stock | |
| BRT Apartments Corp | Mark H. Lundy | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 12,640 | 272,402 (1%) | 0% | 0 | Common Stock | |
| Halliburton | Myrtle L. Jones | Senior Vice Pres - Tax | 05 Jan 2023 | 12,591 | 55,387 (0%) | 0% | 39.4 | 495,456 | Common Stock | |
| Aemetis Inc | Andrew B. Foster | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 12,500 | 12,500 | - | - | Option (right to buy) | |
| Aemetis Inc | Sanjeev Gupta | Executive Vice President, MD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 12,500 | 12,500 | - | - | Option (right to buy) | |
| Aemetis Inc | Todd A. Waltz | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 12,500 | 12,500 | - | - | Option (right to buy) | |
| Robinhood Markets Inc (Class A) | Daniel M Gallagher | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 8.13 per share. | 05 Jan 2023 | 12,500 | 334,573 | - | 8.1 | 101,605 | Class A Common Stock |
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2023 | 12,371 | 75,940 (0%) | 0% | 0 | Common Stock | ||
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2023 | 12,371 | 81,814 | - | - | Restricted Stock / Units | ||
| Orthofix Medical Inc | Kimberley A. Elting | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 12,229 | 164,687 (0%) | 0% | 0 | Common Stock | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 12,000 | 6,665,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 12,000 | 6,653,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 12,000 | 6,641,334 | - | - | Class B Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 12,000 | 594,805 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 12,000 | 582,805 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 12,000 | 594,805 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 12,000 | 582,805 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | 05 Jan 2023 | 12,000 | 594,805 | - | 0 | Class A Common Stock | ||
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Jan 2023 | 12,000 | 582,805 | - | 0 | Class A Common Stock | |
| Orthofix Medical Inc | Kimberley A. Elting | President, Global Orthopedics | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 11,534 | 152,458 (0%) | 0% | 0 | Common Stock | |
| BRT Apartments Corp | Fredric H. Gould | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 11,456 | 384,688 (2%) | 0% | 0 | Common Stock | |
| Ouster Inc (Class A) | Remy W. Trafelet | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 05 Jan 2023 | 11,206 | 1,661,450 | - | 1.1 | 12,499 | Common Stock |
| Aemetis Inc | John R. Block | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 11,070 | 40,161 (0%) | 0% | 0 | Common Stock | |
| Aemetis Inc | Naomi L. Boness | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 11,070 | 31,441 (0%) | 0% | 0 | Common Stock | |
| Aemetis Inc | Timothy Alan Simon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 11,070 | 32,441 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Alfred A. Nietzel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| OneSpan Inc | Michael J. McConnell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marc Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marc D. Boroditsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| OneSpan Inc | Garry L. Capers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marianne Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| OneSpan Inc | Sarika Garg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,823 | 10,823 | - | - | Restricted Stock Units | |
| One Liberty Properties Inc | David W. Kalish | Senior Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,670 | 215,834 (1%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Fredric H. Gould | Director, Vice Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,670 | 540,180 (2%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Mark H. Lundy | Sr. VP & Asst Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,670 | 190,378 (0%) | 0% | 0 | Common Stock | |
| One Liberty Properties Inc | Matthew J. Gould | Director, Chairman of Board | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,670 | 314,281 (1%) | 0% | 0 | Common Stock | |
| Treace Medical Concepts Inc | Richard W. Mott | Director | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 05 Jan 2023 | 10,444 | 1,310,000 | - | 24.0 | 250,677 | Common Stock |
| Ouster Inc (Class A) | Sundari Mitra | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 05 Jan 2023 | 10,085 | 139,313 | - | 1.1 | 11,249 | Common Stock |
| Ouster Inc (Class A) | Karin Radstrom | Director | Grant, award, or other acquisition of securities at price $ 1.12 per share. | 05 Jan 2023 | 10,085 | 147,710 | - | 1.1 | 11,249 | Common Stock |
| V2X Inc | William Wayne Beard | SVP, Aerospace Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.64 per share. | 05 Jan 2023 | 10,034 | 19,281 (0%) | 0% | 41.6 | 417,816 | V2X, Inc. Common Stock |
| PTC Therapeutics Inc | Glenn D. Steele | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | David P. Southwell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Jerome Bernard Zeldis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Allan Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Emma Reeve | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Stephanie S. Okey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Mary Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Alethia Young | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Zentalis Pharma Inc | Cam S. Gallagher | Director, President | Sale of securities on an exchange or to another person at price $ 21.01 per share. | 05 Jan 2023 | 9,700 | 362,311 | - | 21.0 | 203,791 | Common Stock |
| Treace Medical Concepts Inc | Richard W. Mott | Director | Sale of securities on an exchange or to another person at price $ 24.00 per share. | 05 Jan 2023 | 9,556 | 1,320,444 | - | 24.0 | 229,363 | Common Stock |
| Generation Bio Co | Ronald H.W. Cooper | Director | Grant, award, or other acquisition of securities at price $ 5.12 per share. | 05 Jan 2023 | 9,500 | 9,500 | - | 5.1 | 48,640 | Common Stock |
| Iridium Comm Inc | Matthew J. Desch | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.96 per share. | 05 Jan 2023 | 9,208 | 595,091 (0%) | 0% | 60.0 | 552,112 | Common Stock |
| Kirby Corp | Christian G. O’Neil | President-Kirby Inland Marine | Exercise or conversion of derivative security received from the company (such as an option) at price $ 51.23 per share. | 05 Jan 2023 | 9,075 | 27,109 (0%) | 0% | 51.2 | 464,912 | Common Stock, par value $0.10 per share |
| Kirby Corp | Christian G. O’Neil | President-Kirby Inland Marine | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 9,075 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| BRT Apartments Corp | Isaac Kalish | VP and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 9,000 | 113,220 (0%) | 0% | 0 | Common Stock | |
| BRT Apartments Corp | Ryan Baltimore | Chief Operating Officer | 05 Jan 2023 | 9,000 | 65,025 (0%) | 0% | 0 | Common Stock | ||
| Lattice Semiconductor Corp | Mark Edwin Jensen | Director | Sale of securities on an exchange or to another person at price $ 64.55 per share. | 05 Jan 2023 | 9,000 | 97,841 (0%) | 0% | 64.6 | 580,975 | Common Stock |
| Lattice Semiconductor Corp | Mark Edwin Jensen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 9,000 | 9,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lattice Semiconductor Corp | Mark Edwin Jensen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.03 per share. | 05 Jan 2023 | 9,000 | 106,841 (0%) | 0% | 5.0 | 45,270 | Common Stock |
| BRT Apartments Corp | Mitchell K. Gould | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,900 | 200,762 (1%) | 0% | 0 | Common Stock | |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 8,900 | 79,533 (0%) | 0% | - | Common Stock | |
| APA | David A. Pursell | Exec. Vice Pres - Development | Sale or transfer of securities back to the company at price $ 41.76 per share. | 05 Jan 2023 | 8,900 | 70,633 (0%) | 0% | 41.8 | 371,664 | Common Stock |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 8,900 | 84,530 | - | - | Restricted Stock / Units | |
| BWX Tech Inc | Omar Fathi Meguid | SVP and Chief Digital Officer | 05 Jan 2023 | 8,793 | 8,793 | - | - | Restricted Stock Units | ||
| Nephros Inc | Joseph Michael Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,402 | 8,402 (0%) | 0% | 0 | Common Stock | |
| BRT Apartments Corp | George E. Zweier | VICE PRESIDENT - CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,400 | 119,240 (0%) | 0% | 0 | Common Stock | |
| NovoCure Ltd | Asaf Danziger | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 111.23 per share. | 05 Jan 2023 | 8,369 | 30,214 (0%) | 0% | 111.2 | 930,916 | Ordinary Shares |
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 8,343 | 43,659 (0%) | 0% | - | Common Stock | ||
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 8,343 | 86,371 | - | - | Restricted Stock / Units | ||
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 8,343 | 102,117 | - | - | Restricted Stock / Units | ||
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 8,343 | 35,316 (0%) | 0% | 41.8 | 348,404 | Common Stock | |
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 8,343 | 38,599 (0%) | 0% | 0 | Common Stock | ||
| Chesapeake Utilities Corp | Beth W. Cooper | Executive VP & CFO | Grant, award, or other acquisition of securities at price $ 123.60 per share. | 05 Jan 2023 | 8,329 | 88,640 (0%) | 0% | 123.6 | 1,029,464 | Common Stock |
| Viasat Inc | Krishna Nathan | Chief Information Officer | 05 Jan 2023 | 8,323 | 0 (0%) | 0% | 0 | $.0001 par value common stock | ||
| Viasat Inc | Krishna Nathan | Chief Information Officer | 05 Jan 2023 | 8,323 | 35,497 (0%) | 0% | 0 | $.0001 par value common stock | ||
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2023 | 8,247 | 71,072 (0%) | 0% | 41.8 | 344,395 | Common Stock | |
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2023 | 8,247 | 79,319 (0%) | 0% | - | Common Stock | ||
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 05 Jan 2023 | 8,247 | 73,567 | - | - | Restricted Stock / Units | ||
| Insmed Inc | Sara Bonstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,232 | 63,823 (0%) | 0% | - | Common Stock | |
| Kirby Corp | Christian G. O’Neil | President-Kirby Inland Marine | Payment of exercise price or tax liability using portion of securities received from the company at price $ 61.85 per share. | 05 Jan 2023 | 8,184 | 18,925 (0%) | 0% | 61.8 | 506,180 | Common Stock, par value $0.10 per share |
| Ecovyst Inc | Michael Feehan | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.03 per share. | 05 Jan 2023 | 8,180 | 370,899 (0%) | 0% | 9.0 | 73,906 | Common Stock |
| Koppers Holdings Inc | Leroy M. Ball | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,053 | 20,205 | - | - | Restricted Stock Units | |
| PTC Therapeutics Inc | Michael Schmertzler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 8,000 | 117,766 (0%) | 0% | 0 | Common Stock | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.08 per share. | 05 Jan 2023 | 8,000 | 8,130 (0%) | 0% | 113.1 | 904,640 | Common Stock |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 8,000 | 632,000 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 8,000 | 640,000 | - | - | Stock Options | |
| United Therapeutics Corp | Martine A. Rothblatt | Director, CHAIRPERSON & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 113.08 per share. | 05 Jan 2023 | 8,000 | 8,130 (0%) | 0% | 113.1 | 904,640 | Common Stock |
| Genie Energy Ltd (Class B) | William W. Perry | Director | Grant, award, or other acquisition of securities at price $ 10.13 per share. | 05 Jan 2023 | 7,853 | 154,550 (0%) | 0% | 10.1 | 79,590 | Class B Common Stock, $.01 par value per share |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.37 per share. | 05 Jan 2023 | 7,826 | 53,984 (0%) | 0% | 14.4 | 112,460 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 05 Jan 2023 | 7,826 | 46,158 (0%) | 0% | 108 | 845,208 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,826 | 0 | - | - | Options to Buy Ordinary Shares | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.76 per share. | 05 Jan 2023 | 7,734 | 35,232 (0%) | 0% | 41.8 | 322,972 | Common Stock |
| OneSpan Inc | Alfred A. Nietzel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Alfred A. Nietzel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 32,451 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Michael J. McConnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Michael J. McConnell | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 58,026 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Marc Zenner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 37,836 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Marc Zenner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marc D. Boroditsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 28,336 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Marc D. Boroditsky | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Garry L. Capers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 11,157 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Garry L. Capers | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Marianne Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 20,677 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Marianne Johnson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| OneSpan Inc | Sarika Garg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 18,301 (0%) | 0% | 0 | Common Stock | |
| OneSpan Inc | Sarika Garg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,618 | 0 | - | - | Restricted Stock Units | |
| Insmed Inc | Drayton Wise | Chief Commercial Officer | 05 Jan 2023 | 7,598 | 78,051 (0%) | 0% | - | Common Stock | ||
| Insmed Inc | Roger Adsett | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,598 | 138,681 (0%) | 0% | - | Common Stock | |
| Insmed Inc | Martina Flammer | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,598 | 72,656 (0%) | 0% | - | Common Stock | |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 05 Jan 2023 | 7,500 | 413,375 (0%) | 0% | 37.4 | 280,425 | Common Stock |
| Arrowhead Pharma Inc | Patrick O'Brien | COO and General Counsel | Sale of securities on an exchange or to another person at price $ 37.39 per share. | 05 Jan 2023 | 7,500 | 420,875 (0%) | 0% | 37.4 | 280,425 | Common Stock |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.46 per share. | 05 Jan 2023 | 7,500 | 53,658 (0%) | 0% | 11.5 | 85,950 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Sale of securities on an exchange or to another person at price $ 108.00 per share. | 05 Jan 2023 | 7,500 | 46,158 (0%) | 0% | 108 | 810,000 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,500 | 0 | - | - | Options to Buy Ordinary Shares | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.49 per share. | 05 Jan 2023 | 7,496 | 339,841 (0%) | 0% | 55.5 | 415,939 | Common Stock, $0.01 par value |
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 7,403 | 94,714 | - | - | Restricted Stock / Units | ||
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 7,403 | 35,316 (0%) | 0% | 41.8 | 309,149 | Common Stock | |
| APA | D. Clay Bretches | Exec. VP, Operations | 05 Jan 2023 | 7,403 | 42,719 (0%) | 0% | - | Common Stock | ||
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.47 per share. | 05 Jan 2023 | 7,332 | 340,005 (0%) | 0% | 55.5 | 406,694 | Common Stock, $0.01 par value |
| OLB Grp Inc | Herzog John | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 05 Jan 2023 | 7,300 | 919,816 | - | 0.9 | 6,642 | Common Stock |
| Arrowhead Pharma Inc | James Hamilton | Chief Discovery/Trans Medicine | Sale of securities on an exchange or to another person at price $ 37.40 per share. | 05 Jan 2023 | 7,230 | 198,057 (0%) | 0% | 37.4 | 270,402 | Common Stock |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.15 per share. | 05 Jan 2023 | 7,183 | 53,341 (0%) | 0% | 21.1 | 151,920 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Sale of securities on an exchange or to another person at price $ 114.00 per share. | 05 Jan 2023 | 7,183 | 46,158 (0%) | 0% | 114.0 | 818,863 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.15 per share. | 05 Jan 2023 | 7,183 | 53,341 (0%) | 0% | 21.1 | 151,920 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Sale of securities on an exchange or to another person at price $ 120.00 per share. | 05 Jan 2023 | 7,183 | 46,158 (0%) | 0% | 120 | 861,960 | Ordinary Shares |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,183 | 10,479 | - | - | Options to Buy Ordinary Shares | |
| NovoCure Ltd | Frank Leonard | President, CNS Cancers US | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2023 | 7,183 | 17,662 | - | - | Options to Buy Ordinary Shares | |
| Nephros Inc | Arthur H. Amron | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (Right to Buy) | |
| Nephros Inc | Oliver Spandow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (Right to Buy) | |
| Nephros Inc | Alisa Lask | Director | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (right to buy) | ||
| Nephros Inc | Thomas Gwydir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (right to buy) | |
| Nephros Inc | Joseph Michael Harris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 7,080 | 7,080 | - | - | Stock Option (right to buy) | |
| APA | Rebecca A. Hoyt | Sr. VP, Chief Acct Officer | 05 Jan 2023 | 7,046 | 49,247 | - | - | Restricted Stock / Units | ||
| APA | Rebecca A. Hoyt | Sr. VP, Chief Acct Officer | 05 Jan 2023 | 7,046 | 88,137 (0%) | 0% | 0 | Common Stock | ||
| Insmed Inc | William H. Lewis | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 19.80 per share. | 05 Jan 2023 | 7,008 | 249,708 (0%) | 0% | 19.8 | 138,758 | Common Stock |
| Compass Inc (Class A) | Bradley K. Serwin | General Counsel and Secretary | 05 Jan 2023 | 6,991 | 129,320 | - | 2.4 | 16,708 | Class A Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.